neurokinin a (4-10), beta-ala(8)- has been researched along with w 7 in 1 studies
Studies (neurokinin a (4-10), beta-ala(8)-) | Trials (neurokinin a (4-10), beta-ala(8)-) | Recent Studies (post-2010) (neurokinin a (4-10), beta-ala(8)-) | Studies (w 7) | Trials (w 7) | Recent Studies (post-2010) (w 7) |
---|---|---|---|---|---|
71 | 0 | 2 | 1,197 | 0 | 85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baamonde, A; Hidalgo, A; Menéndez, L | 1 |
1 other study(ies) available for neurokinin a (4-10), beta-ala(8)- and w 7
Article | Year |
---|---|
Spinal calmodulin inhibitors reduce N-methyl-D-aspartate- and septide-induced nociceptive behavior.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Enzyme Inhibitors; Imidazoles; Injections, Intraventricular; Male; N-Methylaspartate; Neurokinin A; Pain; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Spinal Cord; Substance P; Sulfonamides | 1997 |